Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

21 mars 2024 18h06 HE | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Investors of Pending Lead Plaintiff Deadline – April 9, 2024 – in Amylyx Pharmaceuticals, Inc. Class Action

Robbins LLP is investigating the allegations that Amylyx Pharmaceuticals, Inc. (AMLX) misled investors regarding RELYVRIO's commercial prospects.
05 mars 2024 16h16 HE | Source: Robbins LLP

AMLX STOCK NEWS: Lead Plaintiff Deadline is Approaching in Class Action Against Amylyx Pharmaceuticals, Inc.; Contact Robbins LLP for Information

Robbins LLP is Investigating the Allegations that Amylyx Pharmaceuticals, Inc. (AMLX) Misled Investors Regarding the Viability of its Drug for Treating ALS
20 févr. 2024 15h18 HE | Source: Robbins LLP

AMLX Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against Amylyx Pharmaceuticals, Inc.

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals Inc.
12 févr. 2024 22h28 HE | Source: Robbins LLP

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Amylyx Pharmaceuticals, Inc. (AMLX)

Robbins LLP is Investigating the Allegations Against Amylyx Pharmaceuticals, Inc.